258 related articles for article (PubMed ID: 29868437)
1. Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images.
Rahmim A; Huang P; Shenkov N; Fotouhi S; Davoodi-Bojd E; Lu L; Mari Z; Soltanian-Zadeh H; Sossi V
Neuroimage Clin; 2017; 16():539-544. PubMed ID: 29868437
[TBL] [Abstract][Full Text] [Related]
2. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
[TBL] [Abstract][Full Text] [Related]
3. Artificial Neural Network-Based Prediction of Outcome in Parkinson's Disease Patients Using DaTscan SPECT Imaging Features.
Tang J; Yang B; Adams MP; Shenkov NN; Klyuzhin IS; Fotouhi S; Davoodi-Bojd E; Lu L; Soltanian-Zadeh H; Sossi V; Rahmim A
Mol Imaging Biol; 2019 Dec; 21(6):1165-1173. PubMed ID: 30847821
[TBL] [Abstract][Full Text] [Related]
4. Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT images.
Adams MP; Rahmim A; Tang J
Comput Biol Med; 2021 May; 132():104312. PubMed ID: 33892414
[TBL] [Abstract][Full Text] [Related]
5. Prospective clinical and DaT-SPECT imaging in premotor
Sierra M; Martínez-Rodríguez I; Sánchez-Juan P; González-Aramburu I; Jiménez-Alonso M; Sánchez-Rodríguez A; Berciano J; Banzo I; Infante J
Neurology; 2017 Aug; 89(5):439-444. PubMed ID: 28679601
[TBL] [Abstract][Full Text] [Related]
6. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Camacho V; Lopez-Mora DA; Pagonabarraga J; Kulisevsky J
Neurobiol Aging; 2021 Jan; 97():120-128. PubMed ID: 33212336
[TBL] [Abstract][Full Text] [Related]
7. Machine learning methods for optimal prediction of motor outcome in Parkinson's disease.
Salmanpour MR; Shamsaei M; Saberi A; Klyuzhin IS; Tang J; Sossi V; Rahmim A
Phys Med; 2020 Jan; 69():233-240. PubMed ID: 31918375
[TBL] [Abstract][Full Text] [Related]
8. Extrastriatal
Nicastro N; Garibotto V; Burkhard PR
BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
[TBL] [Abstract][Full Text] [Related]
9. A tissue-fraction estimation-based segmentation method for quantitative dopamine transporter SPECT.
Liu Z; Moon HS; Li Z; Laforest R; Perlmutter JS; Norris SA; Jha AK
Med Phys; 2022 Aug; 49(8):5121-5137. PubMed ID: 35635327
[TBL] [Abstract][Full Text] [Related]
10. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P
Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156
[TBL] [Abstract][Full Text] [Related]
11. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
12. Combined use of dopamine transporter imaging (DAT-SPECT) and
Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
[TBL] [Abstract][Full Text] [Related]
13. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease.
Yang Z; Xie Y; Dou K; Yang L; Xie A
Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231
[TBL] [Abstract][Full Text] [Related]
14. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
15. Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.
Yousaf T; Pagano G; Niccolini F; Politis M
J Neurol Sci; 2018 Apr; 387():220-227. PubMed ID: 29571867
[TBL] [Abstract][Full Text] [Related]
16. The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.
Stephenson D; Hill D; Cedarbaum JM; Tome M; Vamvakas S; Romero K; Conrado DJ; Dexter DT; Seibyl J; Jennings D; Nicholas T; Matthews D; Xie Z; Imam S; Maguire P; Russell D; Gordon MF; Stebbins GT; Somer E; Gallagher J; Roach A; Basseches P; Grosset D; Marek K;
J Parkinsons Dis; 2019; 9(3):553-563. PubMed ID: 31306141
[TBL] [Abstract][Full Text] [Related]
17. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
18. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
19. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
20. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
